探索局部结肠癌的分子特征:来自AIO Colopredict Plus注册表的见解
Ira Ekmekciu1, Doreen Maria Zucha2, Jens Christmann2
1Department of Hematology, Oncology and Palliative Care, St. Josef Hospital, Ruhr University, Bochum, Germany.
Frontiers in oncology
|December 4, 2024
概括
微卫星稳定 (MSS) 结肠癌与BRAF突变 (MT) 显示了较差的生存结果. 了解这些分子和临床病理学特征是开发向结肠癌治疗的关键.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 结肠癌 (CC) 突变格局对于向治疗至关重要.
- 微卫星不稳定性 (MSI-H),大鼠肉瘤 (RAS) 和B-Raf原瘤基因,氨酸/氨酸激酶 (BRAF) 突变是关键标志物.
- 在微卫星稳定 (MSS) 和MSI-H瘤中RAS和BRAF突变的临床病理特征需要进一步调查.
研究的目的:
- 分析分子亚型 (MSI,RAS,BRAF突变) 与结肠癌中的临床病理特征之间的相关性.
- 评估这些分子变化的对无病生存期 (DFS) 和整体生存期 (OS) 的影响.
- 识别与不同瘤特征和患者结果相关的特定突变概况.
主要方法:
- 对4883名局部结肠癌患者的回顾性分析.
- 对MSI,KRAS,NRAS和BRAF突变进行分子分析.
- 统计分析包括ANOVA,Chi-square测试和Cox比例危险模型用于生存分析.
主要成果:
- 与MSI-H瘤相比,MSS瘤的全野生类型 (WT),KRAS和NRAS突变频率较高.
- 在MSI-H瘤中,BRAF突变,主要是V600E,更为普遍.
- BRAF突变的MSS瘤与右侧位置,女性性别,晚期,淋巴结阳性,差异化和显著更差的DFS和OS有关.
结论:
- 在早期结肠癌中,分子亚型,临床病理特征和生存结果之间存在复杂的相互作用.
- BRAF突变的MSS结肠癌呈现出明显的临床特征,预后较差.
- 需要进一步的研究来了解潜在的机制,并制定针对结肠癌的个性化治疗策略.
更多相关视频
15:17Colorectal Cancer Cell Surface Protein Profiling Using an Antibody Microarray and Fluorescence Multiplexing
Published on: September 25, 2011
13.9K
10:33Molecular Profiling of the Invasive Tumor Microenvironment in a 3-Dimensional Model of Colorectal Cancer Cells and Ex vivo Fibroblasts
Published on: April 29, 2014
11.0K
相关概念视频
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...